G. Bradley Cole's most recent trade in Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A was a trade of 16,798 Share Option done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 16,798 | 16,798 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 3,173 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 3,173 | 12,546 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 2,799 | 2,799 | - | - | Restricted Share Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,667 | 13,667 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 8,673 | 21,964 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 8,673 | 0 | - | - | Restricted Stock Units | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 19,040 | 19,040 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 9,373 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,173 | 3,173 | - | - | Restricted Share Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 8,636 | 13,291 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2024 | 8,636 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 8,673 | 8,673 | - | - | Restricted Stock Units | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 5,000 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 26,236 | 26,236 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 4,373 | 4,373 | - | - | Restricted Share Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 3,825 | 4,655 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2023 | 3,825 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 8,636 | 8,636 | - | - | Restricted Stock Units | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 30,000 | 30,000 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 5,000 | 5,000 | - | - | Restricted Share Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 830 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2022 | 830 | 830 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 7,647 | 7,647 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 3,825 | 3,825 | - | - | Restricted Stock Units | |
| Kiniksa Pharmaceuticals Lt... | G. Bradley Cole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 33,237 | 33,237 | - | - | Share Option |